Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

Parameswaran Nair, Márcia Margaret Menezes Pizzichini, Melanie Kjarsgaard et al. · New England Journal of Medicine · 2009 · 1.3K citations · Full text

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.3K citations

Asthma, Rheumatology, Placebo-controlled Phase 3 +9

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Eugene R. Bleecker, J. Mark FitzGerald, Pascal Chanez et al. · The Lancet · 2016 · 1.3K citations

Asthma, Allergy, Placebo-controlled Phase 3 +10

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

Parameswaran Nair, Sally E. Wenzel, Klaus F. Rabe et al. · New England Journal of Medicine · 2017 · 1K citations · Full text

Reslizumab for Poorly Controlled, Eosinophilic Asthma

Mario Castro, Sameer K. Mathur, Frederick E. Hargreave et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 715 citations